Cargando…

Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing

BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of death in the world, characterized by high morbidity, poor prognosis and high mortality. Histone modifications regulate intracellular gene expression at the post-transcriptional level, and disturbances in the regulatory pattern...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Lei, Xu, Ling, Tian, Shan, Zheng, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470838/
https://www.ncbi.nlm.nih.gov/pubmed/36120466
http://dx.doi.org/10.3389/fendo.2022.965445
_version_ 1784788927451758592
author Fan, Lei
Xu, Ling
Tian, Shan
Zheng, Xin
author_facet Fan, Lei
Xu, Ling
Tian, Shan
Zheng, Xin
author_sort Fan, Lei
collection PubMed
description BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of death in the world, characterized by high morbidity, poor prognosis and high mortality. Histone modifications regulate intracellular gene expression at the post-transcriptional level, and disturbances in the regulatory pattern of histone modifications at individual locus or across the genome can lead to tumorigenesis of HCC. In this study, we constructed a prognosis-related histone phosphorylation regulated (HPR) genes signature and elucidated whether HPR genes can predict overall survival in HCC patients. METHODS: Differentially expressed genes were screened using TCGA, ICGC and GEO databases, and a new risk signature was constructed by univariate Cox regression and Lasso regression analysis. Predictive nomograms were established by multivariate Cox regression of risk scores and clinical parameters, calibration curve and decision curve analysis were used to evaluate the models. The ssGSEA methods were used to determine the effect of risk scores on the tumor immune microenvironment. Data for HCC single-cell RNA sequencing (scRNA-seq) have been downloaded from Gene Expression Omnibus (GEO) to understand the role of HPR genes in tumorigenesis. RESULTS: Our analyses of nine HPR genes provided prognostic insights. Overall survival in the low-risk and high-risk groups was statistically higher, respectively (P<0.001). Cox regression analysis revealed that the risk score is a significant predictor of HCC outcomes (HR=2. 2.62, 95%CI: 1.248-5.514, P=0.011). In addition, a nomogram combining risk scores with TNM stages was constructed and tested from calibration curves and decision curves (AUC=0.780). MHC-class-I genes, iDCs, Macrophages, Tfh, Treg, Th2 were overexpressed in the high-risk group. CONCLUSION: HPR genes risk score is closely related to the prognosis of HCC, tumor immune process and tumor cell progression.
format Online
Article
Text
id pubmed-9470838
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94708382022-09-15 Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing Fan, Lei Xu, Ling Tian, Shan Zheng, Xin Front Endocrinol (Lausanne) Endocrinology BACKGROUND: Hepatocellular carcinoma (HCC) is the third leading cause of death in the world, characterized by high morbidity, poor prognosis and high mortality. Histone modifications regulate intracellular gene expression at the post-transcriptional level, and disturbances in the regulatory pattern of histone modifications at individual locus or across the genome can lead to tumorigenesis of HCC. In this study, we constructed a prognosis-related histone phosphorylation regulated (HPR) genes signature and elucidated whether HPR genes can predict overall survival in HCC patients. METHODS: Differentially expressed genes were screened using TCGA, ICGC and GEO databases, and a new risk signature was constructed by univariate Cox regression and Lasso regression analysis. Predictive nomograms were established by multivariate Cox regression of risk scores and clinical parameters, calibration curve and decision curve analysis were used to evaluate the models. The ssGSEA methods were used to determine the effect of risk scores on the tumor immune microenvironment. Data for HCC single-cell RNA sequencing (scRNA-seq) have been downloaded from Gene Expression Omnibus (GEO) to understand the role of HPR genes in tumorigenesis. RESULTS: Our analyses of nine HPR genes provided prognostic insights. Overall survival in the low-risk and high-risk groups was statistically higher, respectively (P<0.001). Cox regression analysis revealed that the risk score is a significant predictor of HCC outcomes (HR=2. 2.62, 95%CI: 1.248-5.514, P=0.011). In addition, a nomogram combining risk scores with TNM stages was constructed and tested from calibration curves and decision curves (AUC=0.780). MHC-class-I genes, iDCs, Macrophages, Tfh, Treg, Th2 were overexpressed in the high-risk group. CONCLUSION: HPR genes risk score is closely related to the prognosis of HCC, tumor immune process and tumor cell progression. Frontiers Media S.A. 2022-08-31 /pmc/articles/PMC9470838/ /pubmed/36120466 http://dx.doi.org/10.3389/fendo.2022.965445 Text en Copyright © 2022 Fan, Xu, Tian and Zheng https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Fan, Lei
Xu, Ling
Tian, Shan
Zheng, Xin
Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing
title Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing
title_full Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing
title_fullStr Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing
title_full_unstemmed Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing
title_short Identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell RNA sequencing
title_sort identification of a novel histone phosphorylation prognostic signature in hepatocellular carcinoma based on bulk and single-cell rna sequencing
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470838/
https://www.ncbi.nlm.nih.gov/pubmed/36120466
http://dx.doi.org/10.3389/fendo.2022.965445
work_keys_str_mv AT fanlei identificationofanovelhistonephosphorylationprognosticsignatureinhepatocellularcarcinomabasedonbulkandsinglecellrnasequencing
AT xuling identificationofanovelhistonephosphorylationprognosticsignatureinhepatocellularcarcinomabasedonbulkandsinglecellrnasequencing
AT tianshan identificationofanovelhistonephosphorylationprognosticsignatureinhepatocellularcarcinomabasedonbulkandsinglecellrnasequencing
AT zhengxin identificationofanovelhistonephosphorylationprognosticsignatureinhepatocellularcarcinomabasedonbulkandsinglecellrnasequencing